Both in Pharmaceuticals
Collegium Pharmaceutical vs Arbutus Biopharma
Over the past year COLL returned −34.3% and ABUS returned −11.6%; their daily moves had a correlation of 0.16.
COLL −34.3% ABUS −11.6%Growth of $1, one year, split-adjusted
| Metric | COLL | ABUS |
|---|---|---|
| Price | $23.71 | $4.05 |
| Market cap | $771.9M | $802.3M |
| Today | −0.08% | +4.38% |
| 1 month | +8.4% | −9.6% |
| 6 months | −35.1% | −8.4% |
| Year to date | −48.8% | −15.8% |
| 1 year | −34.3% | −11.6% |
| Revenue growth (YoY) | +6.3% | −90.6% |
| Gross margin | 86.7% | 100.0% |
| Net margin | −7.5% | −512.0% |
| P/E (TTM) | 16.1× | 5.2× |
| Price / sales | 1.0× | 4.4× |
| Net cash | -$962.1M | $89.5M |
| Dividend yield | — | — |
| Volatility (60d) | 33.9% | 38.1% |
| Short % of float | 17.6% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).